 | • レポートコード：MRC2012A9231 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、スニチニブリンゴ酸塩の世界市場を広く調査・分析し、今後の市場展望をまとめております。スニチニブリンゴ酸塩の種類別市場規模（純度：99％以上、純度：98％以上、純度：97％以上）、用途別市場規模（膵神経内分泌腫瘍、腎臓がん、消化管間質腫瘍）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、J&K Scientific、Topcarepharm、Njfirstpharm、Targetmol、 ・地域別グローバル市場分析 2015年-2020年 ・スニチニブリンゴ酸塩の北米市場（アメリカ、カナダ、メキシコ） ・スニチニブリンゴ酸塩のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・スニチニブリンゴ酸塩のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・スニチニブリンゴ酸塩の南米市場（ブラジル、アルゼンチン） ・スニチニブリンゴ酸塩の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：純度：99％以上、純度：98％以上、純度：97％以上 ・用途別分析：膵神経内分泌腫瘍、腎臓がん、消化管間質腫瘍 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Sunitinib Malate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.5% in the forecast period of 2020 to 2025 and will expected to reach USD 65 million by 2025, from USD 49 million in 2019.
The Sunitinib Malate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sunitinib Malate market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sunitinib Malate market has been segmented into
Purity: Above 99%
Purity: Above 98%
Purity: Above 97%
By Application, Sunitinib Malate has been segmented into:
Pancreatic Neuroendocrine Tumors
Kidney Cancer
Gastrointestinal stromal tumor
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sunitinib Malate market presented in the report. This section sheds light on the sales growth of different regional and country-level Sunitinib Malate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sunitinib Malate market.
The report offers in-depth assessment of the growth and other aspects of the Sunitinib Malate market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Sunitinib Malate Market Share Analysis
Sunitinib Malate competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sunitinib Malate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sunitinib Malate sales, revenue and market share for each player covered in this report.
The major players covered in Sunitinib Malate are:
Pfizer
J&K Scientific
Topcarepharm
Njfirstpharm
Targetmol
Among other players domestic and global, Sunitinib Malate market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sunitinib Malate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sunitinib Malate, with price, sales, revenue and global market share of Sunitinib Malate in 2018 and 2019.
Chapter 3, the Sunitinib Malate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sunitinib Malate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sunitinib Malate market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sunitinib Malate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Sunitinib Malate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sunitinib Malate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Purity: Above 99%
1.2.3 Purity: Above 98%
1.2.4 Purity: Above 97%
1.3 Market Analysis by Application
1.3.1 Overview: Global Sunitinib Malate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pancreatic Neuroendocrine Tumors
1.3.3 Kidney Cancer
1.3.4 Gastrointestinal stromal tumor
1.4 Overview of Global Sunitinib Malate Market
1.4.1 Global Sunitinib Malate Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 J&K Scientific
2.2.1 J&K Scientific Details
2.2.2 J&K Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 J&K Scientific SWOT Analysis
2.2.4 J&K Scientific Product and Services
2.2.5 J&K Scientific Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Topcarepharm
2.3.1 Topcarepharm Details
2.3.2 Topcarepharm Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Topcarepharm SWOT Analysis
2.3.4 Topcarepharm Product and Services
2.3.5 Topcarepharm Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Njfirstpharm
2.4.1 Njfirstpharm Details
2.4.2 Njfirstpharm Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Njfirstpharm SWOT Analysis
2.4.4 Njfirstpharm Product and Services
2.4.5 Njfirstpharm Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Targetmol
2.5.1 Targetmol Details
2.5.2 Targetmol Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Targetmol SWOT Analysis
2.5.4 Targetmol Product and Services
2.5.5 Targetmol Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sunitinib Malate Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sunitinib Malate Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sunitinib Malate Manufacturer Market Share in 2019
3.3.2 Top 6 Sunitinib Malate Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sunitinib Malate Sales, Revenue and Market Share by Regions
4.1.1 Global Sunitinib Malate Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sunitinib Malate Revenue and Market Share by Regions (2015-2020)
4.2 North America Sunitinib Malate Sales and Growth Rate (2015-2020)
4.3 Europe Sunitinib Malate Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sunitinib Malate Sales and Growth Rate (2015-2020)
4.5 South America Sunitinib Malate Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sunitinib Malate Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sunitinib Malate Sales, Revenue and Market Share by Country
5.1.1 North America Sunitinib Malate Sales and Market Share by Country (2015-2020)
5.1.2 North America Sunitinib Malate Revenue and Market Share by Country (2015-2020)
5.2 United States Sunitinib Malate Sales and Growth Rate (2015-2020)
5.3 Canada Sunitinib Malate Sales and Growth Rate (2015-2020)
5.4 Mexico Sunitinib Malate Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sunitinib Malate Sales, Revenue and Market Share by Country
6.1.1 Europe Sunitinib Malate Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sunitinib Malate Revenue and Market Share by Country (2015-2020)
6.2 Germany Sunitinib Malate Sales and Growth Rate (2015-2020)
6.3 UK Sunitinib Malate Sales and Growth Rate (2015-2020)
6.4 France Sunitinib Malate Sales and Growth Rate (2015-2020)
6.5 Russia Sunitinib Malate Sales and Growth Rate (2015-2020)
6.6 Italy Sunitinib Malate Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sunitinib Malate Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sunitinib Malate Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sunitinib Malate Revenue and Market Share by Regions (2015-2020)
7.2 China Sunitinib Malate Sales and Growth Rate (2015-2020)
7.3 Japan Sunitinib Malate Sales and Growth Rate (2015-2020)
7.4 Korea Sunitinib Malate Sales and Growth Rate (2015-2020)
7.5 India Sunitinib Malate Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sunitinib Malate Sales and Growth Rate (2015-2020)
7.7 Australia Sunitinib Malate Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sunitinib Malate Sales, Revenue and Market Share by Country
8.1.1 South America Sunitinib Malate Sales and Market Share by Country (2015-2020)
8.1.2 South America Sunitinib Malate Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sunitinib Malate Sales and Growth Rate (2015-2020)
8.3 Argentina Sunitinib Malate Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sunitinib Malate Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sunitinib Malate Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sunitinib Malate Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sunitinib Malate Sales and Growth Rate (2015-2020)
9.3 Turkey Sunitinib Malate Sales and Growth Rate (2015-2020)
9.4 Egypt Sunitinib Malate Sales and Growth Rate (2015-2020)
9.5 South Africa Sunitinib Malate Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sunitinib Malate Sales and Market Share by Type (2015-2020)
10.2 Global Sunitinib Malate Revenue and Market Share by Type (2015-2020)
10.3 Global Sunitinib Malate Price by Type (2015-2020)
11 Global Sunitinib Malate Market Segment by Application
11.1 Global Sunitinib Malate Sales Market Share by Application (2015-2020)
11.2 Global Sunitinib Malate Revenue Market Share by Application (2015-2020)
11.3 Global Sunitinib Malate Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sunitinib Malate Sales, Revenue and Growth Rate (2021-2025)
12.2 Sunitinib Malate Market Forecast by Regions (2021-2025)
12.2.1 North America Sunitinib Malate Market Forecast (2021-2025)
12.2.2 Europe Sunitinib Malate Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sunitinib Malate Market Forecast (2021-2025)
12.2.4 South America Sunitinib Malate Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sunitinib Malate Market Forecast (2021-2025)
12.3 Sunitinib Malate Market Forecast by Type (2021-2025)
12.3.1 Global Sunitinib Malate Sales Forecast by Type (2021-2025)
12.3.2 Global Sunitinib Malate Market Share Forecast by Type (2021-2025)
12.4 Sunitinib Malate Market Forecast by Application (2021-2025)
12.4.1 Global Sunitinib Malate Sales Forecast by Application (2021-2025)
12.4.2 Global Sunitinib Malate Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Sunitinib Malate Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sunitinib Malate by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sunitinib Malate Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Sunitinib Malate Major Business
Table 9. Pfizer Sunitinib Malate Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Sunitinib Malate Product and Services
Table 12. Pfizer Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. J&K Scientific Basic Information, Manufacturing Base and Competitors
Table 14. J&K Scientific Sunitinib Malate Major Business
Table 15. J&K Scientific Sunitinib Malate Total Revenue (USD Million) (2018-2019)
Table 16. J&K Scientific SWOT Analysis
Table 17. J&K Scientific Sunitinib Malate Product and Services
Table 18. J&K Scientific Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Topcarepharm Basic Information, Manufacturing Base and Competitors
Table 20. Topcarepharm Sunitinib Malate Major Business
Table 21. Topcarepharm Sunitinib Malate Total Revenue (USD Million) (2018-2019)
Table 22. Topcarepharm SWOT Analysis
Table 23. Topcarepharm Sunitinib Malate Product and Services
Table 24. Topcarepharm Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Njfirstpharm Basic Information, Manufacturing Base and Competitors
Table 26. Njfirstpharm Sunitinib Malate Major Business
Table 27. Njfirstpharm Sunitinib Malate Total Revenue (USD Million) (2018-2019)
Table 28. Njfirstpharm SWOT Analysis
Table 29. Njfirstpharm Sunitinib Malate Product and Services
Table 30. Njfirstpharm Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Targetmol Basic Information, Manufacturing Base and Competitors
Table 32. Targetmol Sunitinib Malate Major Business
Table 33. Targetmol Sunitinib Malate Total Revenue (USD Million) (2018-2019)
Table 34. Targetmol SWOT Analysis
Table 35. Targetmol Sunitinib Malate Product and Services
Table 36. Targetmol Sunitinib Malate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Sunitinib Malate Sales by Manufacturer (2018-2019) (MT)
Table 38. Global Sunitinib Malate Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Sunitinib Malate Sales by Regions (2015-2020) (MT)
Table 40. Global Sunitinib Malate Sales Market Share by Regions (2015-2020)
Table 41. Global Sunitinib Malate Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Sunitinib Malate Sales by Countries (2015-2020) (MT)
Table 43. North America Sunitinib Malate Sales Market Share by Countries (2015-2020)
Table 44. North America Sunitinib Malate Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Sunitinib Malate Revenue Market Share by Countries (2015-2020)
Table 46. Europe Sunitinib Malate Sales by Countries (2015-2020) (MT)
Table 47. Europe Sunitinib Malate Sales Market Share by Countries (2015-2020)
Table 48. Europe Sunitinib Malate Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Sunitinib Malate Sales by Regions (2015-2020) (MT)
Table 50. Asia-Pacific Sunitinib Malate Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Sunitinib Malate Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Sunitinib Malate Sales by Countries (2015-2020) (MT)
Table 53. South America Sunitinib Malate Sales Market Share by Countries (2015-2020)
Table 54. South America Sunitinib Malate Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Sunitinib Malate Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Sunitinib Malate Sales by Countries (2015-2020) (MT)
Table 57. Middle East & Africa Sunitinib Malate Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Sunitinib Malate Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Sunitinib Malate Revenue Market Share by Countries (2015-2020)
Table 60. Global Sunitinib Malate Sales by Type (2015-2020) (MT)
Table 61. Global Sunitinib Malate Sales Share by Type (2015-2020)
Table 62. Global Sunitinib Malate Revenue by Type (2015-2020) (USD Million)
Table 63. Global Sunitinib Malate Revenue Share by Type (2015-2020)
Table 64. Global Sunitinib Malate Sales by Application (2015-2020) (MT)
Table 65. Global Sunitinib Malate Sales Share by Application (2015-2020)
Table 66. Global Sunitinib Malate Sales Forecast by Regions (2021-2025) (MT)
Table 67. Global Sunitinib Malate Market Share Forecast by Regions (2021-2025)
Table 68. Global Sunitinib Malate Sales Forecast by Type (2021-2025) (MT)
Table 69. Global Sunitinib Malate Market Share Forecast by Type (2021-2025)
Table 70. Global Sunitinib Malate Sales Forecast by Application (2021-2025)
Table 71. Global Sunitinib Malate Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sunitinib Malate Picture
Figure 2. Global Sales Market Share of Sunitinib Malate by Type in 2019
Figure 3. Purity: Above 99% Picture
Figure 4. Purity: Above 98% Picture
Figure 5. Purity: Above 97% Picture
Figure 6. Sunitinib Malate Sales Market Share by Application in 2018
Figure 7. Pancreatic Neuroendocrine Tumors Picture
Figure 8. Kidney Cancer Picture
Figure 9. Gastrointestinal stromal tumor Picture
Figure 10. Global Sunitinib Malate Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Sunitinib Malate Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Sunitinib Malate Sales Market Share by Manufacturer in 2019
Figure 31. Global Sunitinib Malate Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Sunitinib Malate Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Sunitinib Malate Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Sunitinib Malate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Sunitinib Malate Revenue Market Share by Regions (2015-2020)
Figure 38. Global Sunitinib Malate Revenue Market Share by Regions in 2018
Figure 39. North America Sunitinib Malate Sales and Growth Rate (2015-2020)
Figure 40. Europe Sunitinib Malate Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Sunitinib Malate Sales and Growth Rate (2015-2020)
Figure 42. South America Sunitinib Malate Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Sunitinib Malate Sales and Growth Rate (2015-2020)
Figure 44. North America Sunitinib Malate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Sunitinib Malate Sales Market Share by Countries (2015-2020)
Figure 46. North America Sunitinib Malate Sales Market Share by Countries in 2018
Figure 47. North America Sunitinib Malate Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Sunitinib Malate Revenue Market Share by Countries in 2018
Figure 49. United States Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Sunitinib Malate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Sunitinib Malate Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Sunitinib Malate Revenue Market Share by Countries in 2019
Figure 55. Germany Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Sunitinib Malate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Sunitinib Malate Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Sunitinib Malate Revenue Market Share by Regions 2019
Figure 63. China Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Sunitinib Malate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Sunitinib Malate Sales Market Share by Countries in 2019
Figure 70. South America Sunitinib Malate Revenue Market Share by Countries in 2019
Figure 71. Brazil Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Sunitinib Malate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Sunitinib Malate Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Sunitinib Malate Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Sunitinib Malate Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Sunitinib Malate Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Sunitinib Malate Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Sunitinib Malate Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Sunitinib Malate Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Sunitinib Malate Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Sunitinib Malate Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Sunitinib Malate Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Sunitinib Malate Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
スニチニブリンゴ酸塩の世界市場（～2026年） The demand of sunitinib malate is increasing, and global advancement of technology and increasing prevalence of pancreatic cancer are the prime growth drivers of the global sunitinib malate market. Market Analysis and Insights: Global Sunitinib Malate Market The global Sunitinib Malate market size i…- クエン酸リンゴ酸カルシウムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Calcium Citrate Malate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Calcium Citrate Malate…
- 消化管間質腫瘍（GIST）の世界市場（～2026年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 消化管間質腫瘍（GIST）治療の世界市場（～2026年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 消化管間質腫瘍（GIST）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gastrointestinal Stromal Tumor (GIST) Drug Market The global Gastrointestinal Stromal Tumor (GIST) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastrointestinal Stromal Tumo…